GFAP and Parkinson disease: When the PD-NC patients were divided into amnestic and non-amnestic groups, no significant differences were found in the clinical characteristics (Supplementary Table S2) and the levels of plasma and neuronal EV α-syn, Aβ42/Aβ40 ratio, p-tau181, and GFAP (Table 2).